President Donald Trump’s Health and Human Services nominee said he will divest his interest in lawsuits against an HPV ...

Kennedy Jr. is revising his ethics agreement to divest his interest in litigation against an HPV vaccine maker and directing ...

Kennedy Jr. earned more than $2.4 million as a consultant referring cases to the law firm Wisner Baum, government records show. Wisner Baum is suing Merck & Co. over allegations that the ...

Robert F. Kennedy Jr., President Trump’s nominee to be health secretary, would have oversight power over the vaccine’s maker, Merck, if confirmed.

President-elect Donald Trump's pick to lead HHS has a long history of discounting and peddling misinformation about the HPV ...

RFK Jr. played a lead role in building a case against Merck's HPV vaccine and could profit from the lawsuit alleging fraud, even if confirmed as health secretary.

A show trial is an official proceeding that is conducted primarily for propaganda purposes rather than a tribunal seeking ...

Robert F. Kennedy Jr. attempted to walk back his past anti-vaccine and pro-abortion rights stances in his Senate confirmation ...

Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year.

Merck faces headwinds like declining sales of the HPV vaccine, Gardasil, and diabetes drug, Januvia. Merck faces broader industry pressure as vaccine skeptic Robert F. Kennedy Jr. possibly next ...

Robert F. Kennedy Jr., President Trump’s nominee to be health secretary, would have oversight power over the vaccine’s maker, Merck, if confirmed. By Christina Jewett and Sheryl Gay Stolberg ...